Mapping of the protein-binding interface between splicing factors SF3b155 and p14 of Trypanosoma cruzi

Biochemical and Biophysical Research Communications

Volumn 364, Issue 1, 2007, Pages 26-32

  Avila, M Lara ^a   Bercovich, Natalia ^a   Westergaard, Gastón ^a   Levin, Mariano J ^b   Vázquez, Martín P ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUT COCHIN   (France)

Author keywords

Drug targets; Protein interaction; Trans splicing

Indexed keywords

ALANINE; MESSENGER RNA; PROTEIN DERIVATIVE; PROTEIN P14; SF3B155 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; DNA SPLICING; GENE MAPPING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING; SPLICEOSOME; TRYPANOSOMA; TRYPANOSOMA CRUZI;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS; RIBONUCLEOPROTEIN, U2 SMALL NUCLEAR; RNA-BINDING PROTEINS; SPLICEOSOMES; TRYPANOSOMA CRUZI;

EUKARYOTA; MAMMALIA; TRYPANOSOMA CRUZI;

EID: 35348959421     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.09.090     Document Type: Article

References (20)

1. Clayton C.E. Life without transcriptional control? From fly to man and back again. EMBO J. 21 (2002) 1881-1888
2. El-Sayed N.M., Myler P.J., Blandin G., Berriman M., Crabtree J., Aggarwal G., Caler E., Renauld H., Worthey E.A., Hertz-Fowler C., Ghedin E., Peacock C., Bartholomeu D.C., Haas B.J., N Tran A., Wortman J.R., Alsmark U.C., Angiuoli S., Anupama A., Badger J., Bringaud F., Cadag E., Carlton J.M., Cerqueira G.C., Creasy T., Delcher A.L., Djikeng A., Embley T.M., Hauser C., Ivens A.C., Kummerfeld S.K., Pereira-Leal J.B., Nilsson D., Peterson J., Salzberg S.L., Shallom J., Silva J.C., Sundaram J., Westenberger S., White O., Melville S.E., Donelson J.E., Andersson B., Stuart K.D., and Hall N. Comparative genomics of trypanosomatid parasitic protozoa. Science 309 (2005) 404-409
3. Docampo R. Sensitivity of parasites to free radical damage by antiparasitic drugs. Chem. Biol. Interact. 73 (1990) 1-27
4. Liang X.H., Haritan A., Uliel S., and Michaeli S. trans and cis splicing in trypanosomatids: mechanism, factors and regulation. Eukaryot. Cell 2 (2003) 830-840
5. Vázquez M., Atorrasagasti C., Bercovich N., Volcovich R., and Levin M.J. Unique features of the Trypanosoma cruzi U2AF35 splicing factor. Mol. Biochem. Parasitol. 128 (2003) 77-81
6. Brosi R., Hauri H.P., and Krämer A. Separation of splicing factor SF3 into two components and purification of SF3a activity. J. Bio. Chem. 268 (1993) 17640-17646
7. Cass D.M., and Berglund J.A. The SF3b155 N-terminal domain is a scaffold important for splicing. Biochemistry 45 (2006) 10092-10101
8. Golas M.M., Sander B., Will C.L., Lührmann R., and Stark H. Molecular architecture of the multiprotein splicing Factor SF3b. Science 300 (2003) 980-984
9. Will C.L., Schneider C., MacMillan A.M., Katopodis N.F., Neubauer G., Will M., Lührmann R., and Query C.C. A novel U2 and U11/U12 snRNP protein that associates with the pre-mRNA branch site. EMBO J. 20 (2001) 4536-4546
10. Spadaccini R., Reist U., Dybkov O., Will C., Frank R., Stier G., Corsini L., Wahl M.C., Lührmann R., and Sattler M. Biochemical and NMR analyses of an SF3b155-p14-U2AF-RNA interaction network involved in branch point definition during pre-mRNA splicing. RNA 12 (2006) 410-425
11. Schellenberg M.J., Edwards R.A., Ritchie D.B., Kent O.A., Golas M.M., Stark H., Lührmann R., Glover M., and MacMillan A.M. Crystal structure of core spliceosomal protein interface. Proc. Natl. Acad. Sci. USA 103 (2006) 1266-1271
12. Horton R.M. PCR-mediated recombination and mutagenesis SOEing together tailor-made genes. Mol. Biotechnol. 3 (1995) 93-99
13. Caro F., Bercovich N., Atorrasagasti C., Levin M.J., and Vázquez M.P. Protein interactions within the TcZFP zinc finger family members of Trypanosoma cruzi: implications for their functions. Biochem. Biophys. Res. Commun. 333 (2005) 1017-1025
14. Reed R. Initial splice site recognition and pairing during pre-mRNA splicing. Curr. Opin. Genet. Dev. 6 (1996) 215-220
15. Eilbracht J., and Schmidt-Zachmann M.S. Identification of a sequence element directing a protein to nuclear speckles. Proc. Natl. Acad. Sci. USA 98 (2001) 3849-3854
16. Thickman K.R., Swenson M.C., Kabogo J.M., Gryczynski Z., and Kielkopf C.L. Multiple U2AF65 Binding Sites within SF3b155: thermodynamic and spectroscopic characterization of protein-protein interactions among pre-mRNA Splicing Factors. J. Mol. Biol. 356 (2006) 664-683
17. Rymond B. Targeting the spliceosome. Nat. Chem. Biol. 3 (2007) 533-535
18. Kotake Y., Sagane K., Owa T., Mimori-Kiyosue Y., Shimizu H., Uesugi M., Ishihama Y., Iwata M., and Mizui Y. Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat. Chem. Biol. 3 (2007) 570-575
19. Kaida D., Motoyoshi H., Tashiro E., Nojima T., Hagiwara M., Ishigami K., Watanabe H., Kitahara T., Yoshida T., Nakajima H., Tani T., Horinouchi S., and Yoshida M. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat. Chem. Biol. 3 (2007) 576-583
20. Zeng J. Mini-review: computational structure-based design of inhibitors that target protein surfaces. Comb. Chem. High Throughput Screen 3 (2000) 355-362